Risk for death significantly increased for head and neck MCC compared with other body regions

Significantly more patients achieved Hand and Foot Investigator's Global Assessment score of 0 or 1

T category and stage at presentation higher for non-Hispanic Black patients

One-third of psoriatic arthritis patients have atopic diseases, most often dermatitis versus atopic rhinitis and allergic asthma

Dose-response relationship seen for number of antibiotic courses and atopic dermatitis risk

Improvement seen in acne-induced hyperpigmentation overall disease severity score at week 12, but not week 24

Reconstruction algorithm with a 50 percent cutoff value is suggested based on cohort of 34 patients

Greater improvements seen in hematologic abnormalities for patients with clinical response to adalimumab

The first Monday in May is Melanoma Monday—explore its role in advancing public health and how dermatologists can spread its message to their patients

Final definition is 'systemic inflammatory disease characterized by cutaneous erythema and macroscopically visible sterile pustules'

Subsequent increase seen for men, no change for women; no temporal trends in mortality noted during 1999 to 2019

Stigma correlates with depression and differs based on level of severity and visibility

Achievement of ≥75 percent reduction in Psoriasis Area and Severity Index lower in both current, former smokers

Improvements seen in patient-reported outcome measures, including Patient-Oriented Eczema Measure, Dermatology Life Quality Index

Low scores seen for perceived stigmatization and body image concerns; satisfaction with facial appearance, psychological distress improved

Greater negative impact seen among patients with severe atopic dermatitis

Common manifestations include neutrophilic dermatoses, vasculitis, granulomatous, connective tissue disease

Reduction seen in mean number of days with moderate-to-extreme flushing, moderate-to-severe erythema

Seven of 10 infants had near-total or total clearance after two months with once-weekly treatments

Less heterogeneity in sensitivity, specificity, accuracy seen when clinicians worked in unison with artificial intelligence

Zevtera approved for S. aureus bloodstream infections, acute bacterial skin/skin structure infections, and bacterial pneumonia

Improvement seen in all signs of photoaging as early as week 4 and through 12 weeks, with no major irritation